Truist Financial
BNTX icon

Truist Financial’s BioNTech BNTX Stock Holding History

Truist Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,519
Closed -$287K – 2560
2024
Q4 		$287K Sell
2,519
-890
-26% -$102K ﹤0.01% 2185
2024
Q3 		$405K Sell
3,409
-12,375
-78% -$1.14M ﹤0.01% 1975
2024
Q2 		$1.27M Sell
15,784
-678
-4% -$62K ﹤0.01% 1496
2024
Q1 		$1.52M Buy
16,462
+2,768
+20% +$265K ﹤0.01% 1416
2023
Q4 		$1.45M Buy
+13,694
New +$1.38M ﹤0.01% 1423
2023
Q2 		– Sell
-2,266
Closed -$282K – 2574
2023
Q1 		$282K Buy
+2,266
New +$311K ﹤0.01% 2273
2022
Q1 		– Sell
-5,416
Closed -$1.4M – 2694
2021
Q4 		$1.4M Buy
5,416
+2,089
+63% +$572K ﹤0.01% 1464
2021
Q3 		$908K Buy
3,327
+1,047
+46% +$333K ﹤0.01% 1667
2021
Q2 		$510K Buy
+2,280
New +$430K ﹤0.01% 2036

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Truist Financial's BNTX Position: Q1 2025 in Review

Truist Financial sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 2,519 shares — an estimated $287K sold.

Truist Financial first reported a position in BNTX in Q2 2021 and held it in 9 quarters. The position peaked at $1.52M in Q1 2024. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Truist Financial reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Truist Financial sold 2,519 BioNTech shares in Q1 2025, an estimated $287K.
  • Truist Financial first reported a position in BioNTech in Q2 2021 and held it in 9 quarters.
  • Truist Financial's BioNTech position peaked at $1.52M in Q1 2024.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.